STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
31 hedge funds and large institutions have $12.7M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
$145K
Puts
–
Top Buyers
| 1 | +$223K | |
| 2 | +$85K | |
| 3 | +$34.9K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$32K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$12.8K |
Top Sellers
| 1 | -$735K | |
| 2 | -$488K | |
| 3 | -$157K | |
| 4 |
Renaissance Technologies
New York
|
-$62.6K |
| 5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$54.3K |
